Profile_bird

Hey there! eMPR is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving eMPR's tweets.

Already using Twitter
from your phone? Click here.

eMPR

  1. MPR News: FDA accepts NDA for extended release Aricept, a treatment for Alzheimer's disease (AD): Eisai and Pfizer ... http://bit.ly/6GSvRg
  2. MPR News: BLA submitted for Zalbin, a treatment for chronic hepatitis C (HCV): Human Genome Sciences announced that... http://bit.ly/5xACaP
  3. MPR News: VAGIFEM: How supplied updated. http://bit.ly/4DeTis
  4. MPR News: ZEVALIN: Indications: approved for previously untreated follicular non-Hodgkin's lymphoma in patients who... http://bit.ly/4p3SwZ
  5. MPR News: Revised Peramivir IV renal dosing recommendations for H1N1 influenza: The FDA has updated the Peramivir I... http://bit.ly/5bvVKy
  6. MPR News: Phase 2 study of LX1031 for the treatment of non-constipating irritable bowel syndrome (IBS): Lexicon Pha... http://bit.ly/91SCqU
  7. MPR News: Phase 2 trial of plinabulin (NPI-2358) for the treatment of advanced non-small cell lung cancer (NSCLC): ... http://bit.ly/8KTj8U
  8. MPR News: FDA to evaluate risk of cardiovascular events with sibutramine: The FDA has notified healthcare professio... http://bit.ly/6Gve9c
  9. MPR News: Abilify approved for irritability associated with autistic disorder: The FDA has approved Abilify (aripip... http://bit.ly/510cxX
  10. MPR News: Naprelan Dose Card blister packs launched: Victory Pharma announces the availability of Naprelan (naproxe... http://bit.ly/76TBOL
  11. MPR News: Phase 2b/3 study of Cinquil for pediatric eosinophilic esophagitis (EoE): Ception Therapeutics and Cephal... http://bit.ly/5Cwp4v
  12. MPR News: DUREZOL: Monograph added. http://bit.ly/5QKzJn
  13. MPR News: Geodon approved for adjunctive maintenance treatment of bipolar I disorder: The FDA has approved Geodon (... http://bit.ly/7IlmwH
  14. MPR News: Vicks Sinex UltraFine Mist Nasal Spray recalled: The FDA and Procter & Gamble have notified consumers of ... http://bit.ly/4v9m0W
  15. MPR News: Intravenous Revatio approved for pulmonary arterial hypertension (PAH): The FDA has approved Revatio (sil... http://bit.ly/3fobnx
  16. MPR News: RockHard Weekend dietary supplement recalled: The FDA and RockHard Laboratories have notified consu... http://tinyurl.com/yek7tfm
  17. MPR News: FOLOTYN: http://bit.ly/3EbG2C
  18. MPR News: SENSIPAR: Monograph added. http://bit.ly/23UgnP
  19. MPR News: SENSIPAR: Monograph added. http://bit.ly/2pbGX9
  20. MPR News: NDA submitted for Brilinta for acute coronary syndromes: AstraZeneca announced that it has submitted a Ne... http://bit.ly/1krEQx